[HTML][HTML] Brain malignancies: Glioblastoma and brain metastases

TT Lah, M Novak, B Breznik - Seminars in cancer biology, 2020 - Elsevier
Brain, the major organ of the central nervous system controls and processes most of body
activities. Therefore, the most aggressive brain tumor–glioblastoma and metastases from …

Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

AF Haddad, JS Young, D Amara… - Neuro-oncology …, 2021 - academic.oup.com
Glioblastoma (GBM) is an incurable brain tumor with a median survival of approximately 15
months despite an aggressive standard of care that includes surgery, chemotherapy, and …

Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells

R Lucero, V Zappulli, A Sammarco, OD Murillo… - Cell reports, 2020 - cell.com
Glioblastoma (GBM) is characterized by aberrant vascularization and a complex tumor
microenvironment. The failure of anti-angiogenic therapies suggests pathways of GBM …

The adaptive transition of glioblastoma stem cells and its implications on treatments

Z Wang, H Zhang, S Xu, Z Liu, Q Cheng - Signal transduction and …, 2021 - nature.com
Glioblastoma is the most malignant tumor occurring in the human central nervous system
with overall median survival time< 14.6 months. Current treatments such as chemotherapy …

Patient-derived glioma models: from patients to dish to animals

CC da Hora, MW Schweiger, T Wurdinger, BA Tannous - Cells, 2019 - mdpi.com
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults
associated with a poor survival. Current standard of care consists of surgical resection …

Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges

G Sun, Z Li, D Rong, H Zhang, X Shi, W Yang… - Molecular Therapy …, 2021 - cell.com
Cancer has become one of the greatest threats to human health, and new technologies are
urgently needed to further clarify the mechanisms of cancer so that better detection and …

Current trends in mouse models of glioblastoma

M Miyai, H Tomita, A Soeda, H Yano, T Iwama… - Journal of neuro …, 2017 - Springer
Glioblastoma is the most deadly brain tumor type and is characterized by a severe and high
rate of angiogenesis, remaining an incurable disease in the majority of cases. Mechanistic …

Immunotherapy of glioblastoma: current strategies and challenges in tumor model development

B Majc, M Novak, N Kopitar-Jerala, A Jewett, B Breznik - Cells, 2021 - mdpi.com
Glioblastoma is the most common brain malignant tumor in the adult population, and
immunotherapy is playing an increasingly central role in the treatment of many cancers …

Utility of glioblastoma patient-derived orthotopic xenografts in drug discovery and personalized therapy

M Patrizii, M Bartucci, SR Pine, HE Sabaawy - Frontiers in oncology, 2018 - frontiersin.org
Despite substantial effort and resources dedicated to drug discovery and development, new
anticancer agents often fail in clinical trials. Among many reasons, the lack of reliable …

Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo

SL Sarli, HH Fakih, K Kelly, G Devi… - Nucleic Acids …, 2024 - academic.oup.com
Glioblastoma multiforme is a universally lethal brain tumor that largely resists current
surgical and drug interventions. Despite important advancements in understanding GBM …